|
Tuesday, 17 October 2006: 10:30 AM-12:00 PM | |||
Ballroom D (Hyatt Regency Cambridge) | |||
Concurrent Abstracts I: Clinical Strategies or Guidelines | |||
Session Chairs: | Kerry Kilbridge Rick Orr | ||
10:30 AM | *A DECISION ANALYSIS EXAMINING TRADEOFFS BETWEEN EFFICACY AND CARDIAC TOXICITY OF ADJUVANT THERAPY WITH HERCEPTIN IN HER2 POSITIVE BREAST CANCER Amit K. Gupta, MD, MS, Sabeen F. Mekan, MD, Mark H. Eckman, MD, MS | ||
10:45 AM | *WHEN IS GENETIC TESTING FOR BREAST CANCER SUSCEPTIBILITY GENES APPROPRIATE? Margaret L. Holland, MS, Katia Noyes, PhD | ||
11:00 AM | USING STATE-TRANSITION SIMULATION MODELING TO INFORM THE DESIGN OF AN HIV CLINICAL STRATEGY TRIAL: PRE-EVALUATION OF AIDS CLINICAL TRIALS GROUP PROTOCOL A5237 Bruce R. Schackman, PhD, Paul E. Sax, MD, Callie A. Scott, BA, Elena Losina, PhD, Timothy J. Wilkin, MD, MPH, John E. McKinnon, MD, MSc, Milton C. Weinstein, PhD, Kenneth A. Freedberg, MD, MSc | ||
11:15 AM | HIV DRUG RESISTANCE SURVEILLANCE FOR PRIORITIZING TREATMENT IN RESOURCE LIMITED SETTINGS Rochelle P. Walensky, MD, MPH, Milton C. Weinstein, PhD, Yazdan Yazdanpanah, MD, PhD, Elena Losina, PhD, Lauren M. Mercincavage, BA, Siaka Toure, MD, Nomita Divi, MS, Xavier Anglaret, MD, Sue J. Goldie, MD, MPH, Kenneth A. Freedberg, MD, MSc | ||
11:30 AM | THE COST-EFFECTIVENESS OF SURVEILLANCE OF BARRETTS OESOPHAGUS - AN INVESTIGATION OF CRITICAL FACTORS Martin A. Pitt, EngD., Ruth Garside, BA, Ken Stein, Margaret Sommerville | ||
11:45 AM | THE NEED FOR EVIDENCE-BASED CARE GUIDELINES: TREATMENT FOR 1ST VERSUS 2ND PRIMARY COLORECTAL CANCER Cathy J. Bradley, PhD, Lynne Penberthy, MD, Donna McClish, PhD, James Shaw, MD |
See more of The 28th Annual Meeting of the Society for Medical Decision Making (October 15-18, 2006)
Papers submitted for the Lee B. Lusted Student Prize Competition are denoted with an asterisk (*)